SRTS sensushealthcare.com Profit After Tax
Sensus Healthcare, Inc. (SRTS) dominates the non-invasive skin cancer treatment niche, offering compact devices for basal cell carcinoma therapy. The organization's net income demonstrates stable dynamics, with the indicator currently at -0.02. Specialized medical logistics ensure the reliability of the systems. However, the risk of prolonged deal cycles and fluctuations in insurance payouts could put pressure on clinic demand.
Financial and market metric breakdowns for Sensus Healthcare (SRTS)
The Sensus Healthcare, Inc. (SRTS) business model is based on the deployment of SRT-100 systems in clinics, which creates a steady revenue stream through service licenses and consumables. By analyzing the company's profit history on GURU.Markets, investors assess the ability of net income to withstand external shocks and determine the volatility of financial results to filter out issuers with unstable cash flows and a high risk of capitalization drawdown.